polyneuropathy


Also found in: Thesaurus, Medical, Financial, Encyclopedia, Wikipedia.
Translations

pol·y·neu·rop·a·thy

n. polineuropatía, enfermedad que afecta varios nervios a la vez.
English-Spanish Medical Dictionary © Farlex 2012

polyneuropathy

n polineuropatía
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
The Company and collaborators presented results from a proteome-wide biomarker analysis of samples from the APOLLO Phase 3 study of ONPATTRO, an RNAi therapeutic for the treatment of the polyneuropathy of hereditary ATTR, or hATTR, amyloidosis in adults.
Akcea will have an on-site presence at the meeting at booth #7 where attendees can learn more about TEGSEDI and hATTR amyloidosis with polyneuropathy. The presentation will be posted on the Akcea website.
M2 PRESSWIRE-August 8, 2019-: Chronic Inflammatory Demyelinating Polyneuropathy Market Therapeutic Assessment and Developments on Essential Factors and Trends Influencing Industry Growth till - 2023
Immunoglobulins are mainly used to treat primary and secondary immunodeficiencies, as well as chronic inflammatory demyelinating polyneuropathy (CIDP).
Polyneuropathy is classified as acute according to the duration between the onset of symptoms and maximal impairment which lasts up to 4 weeks (1).
Conclusion: Cardiac complications of pharyngeal diphtheria were found to be the most common and fatal followed by polyneuropathy.
We present the case of a patient with a history of undifferentiated arthritis who developed two episodes of sensory demyelinating polyneuropathy. Golimumab might have been involved in the etiopathogenesis of these episodes.
Specialist pharmacy Orsini Healthcare Specialty Pharmacy stated on Monday that it plans to distribute ONPATTRO (patisiran) lipid complex injection for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.
THURSDAY, July 5, 2018 (HealthDay News) -- For patients with hereditary transthyretin amyloidosis with polyneuropathy, an investigational RNA interference therapeutic agent (patisiran) and a 2'-O-methoxyethyl-modified antisense oligonucleotide (inotersen), which inhibits hepatic production of transthyretin, improve clinical manifestations of disease, according to two studies published in the July 5 issue of the New England Journal of Medicine.
Objective: The objective of this study is to determine the frequency of carpal tunnel syndrome in patients with diabetic polyneuropathy.
Asymmetric motor and sensory involvement findings could be suggestive of a polyneuropathy; however, normal sensory and motor nerve conduction responses in the upper extremities weaken the probability of polyneuropathy.